Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03342235

Excimer Laser Surgery for Anisometropic Amblyopia

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Jaeb Center for Health Research · Academic / Other
Sex
All
Age
3 Years – 7 Years
Healthy volunteers
Not accepted

Summary

Study Objectives To compare the efficacy and safety of surgical treatment (PRK) versus non-surgical treatment of anisometropic amblyopia in children who have failed conventional treatment due to non-compliance or non-response. Synopsis of Study Design The study consists of two phases: 1. A Patching Run-In Phase during which all participants are treated for at least 8 weeks with continued refractive correction (with spectacles and/or contact lenses) and patching prescribed 42 hours per week (averaging 6 hours daily) until no further improvement over 2 consecutive visits at least 4 weeks apart or the vision no longer meets eligibility criteria. 2. A Randomized Trial Phase, beginning after no further VA improvement in the patching run-in phase and qualifying amblyopia is still present, during which the participant is assigned to either surgery with PRK and patching prescribed 2 hours per day or to non-surgical treatment with continued refractive correction (with spectacles and/or contact lenses) and patching prescribed 2 hours per day.

Detailed description

The study is evaluating the efficacy of surgical treatment with PRK versus non-surgical treatment of anisometropic amblyopia in children who have failed conventional treatment. The primary analysis will be a treatment group comparison of the change in BCVA in the amblyopic eye at the 8-month primary outcome visit. For participants wearing a contact lens, the BCVA will be the visual acuity tested in the contact lens rather than in spectacles (or trial frames).

Conditions

Interventions

TypeNameDescription
PROCEDUREPhotorefractive Keratectomy (PRK)Subjects randomized to refractive surgery will be referred to one of six study surgical centers (surgical centers are listed in Appendix B) to have photorefractive keratectomy (PRK) in the affected eye within 60 days after randomization.
OTHERPatching 2 hours per dayPatching prescribed 2 hours per day with continued refractive correction (with spectacles and/or contact lenses) as able.
DEVICEExcimer Laser SystemExcimer Laser System for use in photorefractive keratectomy.

Timeline

Start date
2020-06-01
Primary completion
2022-03-01
Completion
2024-03-01
First posted
2017-11-14
Last updated
2020-05-20

Regulatory

Source: ClinicalTrials.gov record NCT03342235. Inclusion in this directory is not an endorsement.